Zhuhai Rundu

Zhuhai Rundu Pharmaceutical is a prominent Chinese pharmaceutical company focused on the research, development, and large-scale production of chemical APIs and finished drug products. The company maintains a diverse portfolio with a strong emphasis on cardiovascular, digestive, and anti-infective therapeutic areas. Key commercial products include antihypertensive agents like Valsartan and gastrointestinal treatments such as Rabeprazole Sodium. Rundu is recognized for its expertise in sustained-release and controlled-release drug delivery technologies, which it applies to its own product line and its CDMO services. Publicly listed on the Shenzhen Stock Exchange, the company operates multiple GMP-certified manufacturing sites and serves both domestic and international markets.